Dexterra Group (DXT) Q2 2024 earnings summary

Executive summary

• Q2 2024 delivered strong results with revenue up 18.1% year-over-year to $253.6 million, driven by robust WAFES activity, new IFM contracts, and the CMI acquisition.

• Adjusted EBITDA from continuing operations increased to $29.3 million, up from $25.2 million in Q2 2023 and $19.6 million in Q1 2024.

• The company maintained a strong balance sheet, improved Free Cash Flow generation, and declared a Q3 2024 dividend of $0.0875 per share.

• The sale of the Modular Solutions business for $40 million is expected to close in Q3 2024, with results presented as discontinued operations.

• The company is focused on a capital-light strategy, supporting dividends, share buybacks, and niche acquisitions.

Financial highlights

• Q2 2024 consolidated revenue was $253.6 million, up from $214.7 million in Q2 2023 and $231.6 million in Q1 2024.

• Adjusted EBITDA margin for Q2 2024 was 11.5%, with a 50% annualized Adjusted EBITDA conversion rate achieved.

• Net earnings from continuing operations for Q2 2024 were $12.2 million, with EPS of $0.19.

• Free Cash Flow deficit improved to $(0.6) million in Q2 2024 from $(4.6) million in Q2 2023.

• Dividend declared for Q3 2024 at $0.0875 per share.

Outlook and guidance

• IFM Adjusted EBITDA margin is expected to surpass 6% in the second half of 2024, with continued improvement into 2025.

• WAFES Adjusted EBITDA margin is expected to exceed 15% annually, with high asset utilization and robust demand through 2024 and into 2025.

• Wildfire support activity in Q3 is expected to be higher than Q2 but less than Q3 2023.

• Post-Modular sale, debt/EBITDA is expected to be about 1.0x, with priorities on organic IFM growth and accretive acquisitions.

• The business is being reorganized for better alignment and reporting, with changes expected by year-end.